Marty Makary
Tracked across 17 events · 1140 articles · First seen May 20, 2025 · Last active Jun 16, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Domestic
Impact: Marty Makary>>> resigned as Commissioner of the United States — Food and Drug Administration>>> after a tumultuous tenure marked by clashes with the Donald Trump>>> administration, industry, and public health groups. His departure creates uncertainty for several of his initiatives.
May 08, 2026 · 114 articles
Regulatory
Impact: As the Commissioner of the United States — Food and Drug Administration, Marty Makary is a key figure in implementing the new policy to reduce the number of required studies for drug approval, aiming to speed up drug development.
Feb 18, 2026 · 6 articles
Domestic
Impact: Marty Makary resigned as head of the United States — Food and Drug Administration, widening the leadership gap within the United States — United States Department of Health and Human Services and leaving behind unfinished initiatives.
May 13, 2026 · 6 articles
Regulatory
Impact: Marty Makary resigned as United States — Food and Drug Administration Commissioner, having engineered Tracy Beth Høeg's rapid rise and facing criticism from political allies.
May 15, 2026 · 17 articles
Domestic
Impact: Marty Makary, the United States — Food and Drug Administration Commissioner, announced the agency's actions regarding acetaminophen and leucovorin under the Trump administration's directive.
Sep 22, 2025 · 6 articles
Regulatory
Impact: As Food and Drug Commissioner, Marty Makary signaled the administration's stance on saturated fats and commented on protein guidance.
Jan 07, 2026 · 7 articles
International
Impact: Marty Makary is resigning as the head of the United States — Food and Drug Administration due to difficulties and complaints from health industry executives, anti-abortion activists, and other Trump allies.
May 12, 2026 · 18 articles
International
Impact: Marty Makary resigned as the head of the United States — Food and Drug Administration after a rocky tenure and complaints from various industry groups.
Apr 16, 2026 · 760 articles
Domestic
Impact: Marty Makary, as United States — Food and Drug Administration Commissioner, announced steps to approve leucovorin as a treatment option for patients with low folate levels, potentially including some with autism.
Sep 22, 2025 · 6 articles
International
Impact: Marty Makary is resigning as the head of the United States — Food and Drug Administration after a rocky tenure, drawing complaints from various industry executives and activists.
Apr 30, 2026 · 116 articles
Business
Impact: FDA Commissioner Marty Makary, alongside Robert F. Kennedy Jr., announced steps to eliminate synthetic dyes, supporting the broader regulatory push for cleaner food ingredients.
Oct 01, 2025 · 7 articles
International
Impact: Marty Makary resigned as the United States — Food and Drug Administration Commissioner, contributing to the agency's leadership upheavals.
May 12, 2026 · 17 articles
Kyle Diamantas
predecessor
↔
Marty Makary
Marty Makary led the FDA as commissioner with Kyle Diamantas serving as his depu
Kyle Diamantas
successor
↔
Marty Makary
Kyle Diamantas served as the FDA deputy commissioner under Marty Makary. Followi
United States — Food and Drug Administration
ex-commissioner
↔
Marty Makary
Marty Makary served as the Commissioner of the Food and Drug Administration for
+ 8 more relationships
View on Dashboard
ERGEN INTELLIGENCE
Track Marty Makary live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard